Clinical Trials
2 trialsNCT02304367 2024-05-06
Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT03510455 2021-04-08
BGJ398 for the Treatment of Tumor-Induced Osteomalacia
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated